Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study

BACKGROUND: Patients with diabetic cardiomyopathy have an impaired myocardial glucose handling and distal distribution of coronary atherosclerosis. Trimetazidine, an anti-ischemic metabolic agent, improves myocardial glucose utilization though inhibition of fatty acid oxidation. Aim of the present s...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Cardiovasc Diabetol
Autori principali:	Rosano, Giuseppe MC, Vitale, Cristiana, Sposato, Barbara, Mercuro, Giuseppe, Fini, Massimo
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2003
Soggetti:	Original Investigation
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC305354/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14641923/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1475-2840-2-16
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!